We use Google Analytics to see which pages are read and how the site is used, so we know what to improve. This only runs if you accept. See our privacy notice for details.

Dáil
‹ Ceisteanna ar Pholasaí nó ar Reachtaíocht - Questions on Policy or Legislation

Veozah access for cancer survivors

Summary

Deputy Cronin asks that Veozah be covered for women experiencing menopause after cancer treatment; the Minister will refer the request to Health while noting that independent bodies assess medicines and sustainable access.

I raise the case of Rebecca from Kildare. Twelve years ago following treatment for cervical cancer, Rebecca experienced early medical menopause. Women with cancer in remission are unable to use traditional hormone replacement therapy, HRT, but thankfully, a new drug for cancer survivors by the name of Veozah has been developed. This drug would be a game-changer for young women like Rebecca. However, it is not available under the new HRT scheme and it costs €75 per month. This is a cost that, unfortunately, Rebecca and other women cannot afford. Will due consideration be given to adding Veozah to the HRT scheme to make it accessible to all cancer survivors who need it, not only those who can afford it?

Comment on this

I thank the Deputy for raising this issue on behalf of Rebecca. I will ensure that the Minister for Health is aware of the status of this medicine, Veozah, and that it is given the consideration it needs. I cannot second guess or answer on behalf of the independent bodies that look at the variety of available medicines and whether they are appropriate and can be made available in a sustainable way in Ireland, but I know that these are sensitive matters and for someone who has survived cancer, as Rebecca has, and wants to have a long and healthy life ahead of her, I am sure this is really serious. The Minister, Carroll MacNeill, will be aware of this. I will pass the Deputy's concerns on to her and thank her for raising it.

Comment on this